INSM vs PAYX · rev $731.5M vs P/E 22, rev $6.51B
Insmed Inc (INSM) versus Paychex Inc (PAYX) — a side-by-side from cached financials, not a winner call.
Insmed Inc (INSM) is a biotechnology company listed on US.
Paychex Inc (PAYX) is a software - application company listed on NASDAQ.
Latest reported INSM revenue for 2026-06-30 was $731.5M. Net income was -$176.8M. INSM currently screens at market cap $20.42B.
Latest reported PAYX revenue for 2026-05-31 was $6.51B. Net income was $1.76B. Revenue was up 16.9% from 2025-05-31 to 2026-05-31. PAYX currently screens at market cap $34.96B and trailing P/E 21.5.
INSM currently screens at market cap $20.42B. PAYX currently screens at market cap $34.96B and trailing P/E 21.5.
Not investment advice. Open the INSM and PAYX stock pages for the full models.
Not investment advice.